Compare FG & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | FG | SHC |
|---|---|---|
| Founded | 1959 | 2015 |
| Country | United States | United States |
| Employees | 1173 | 3000 |
| Industry | Life Insurance | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.8B | 4.4B |
| IPO Year | N/A | 2020 |
| Metric | FG | SHC |
|---|---|---|
| Price | $29.46 | $15.19 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 7 |
| Target Price | ★ $31.00 | $20.33 |
| AVG Volume (30 Days) | 490.5K | ★ 2.4M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.52% | N/A |
| EPS Growth | N/A | ★ 68.75 |
| EPS | N/A | ★ 0.27 |
| Revenue | N/A | ★ $1,163,617,000.00 |
| Revenue This Year | $7.94 | $7.51 |
| Revenue Next Year | $5.51 | $6.00 |
| P/E Ratio | ★ $8.41 | $57.04 |
| Revenue Growth | N/A | ★ 5.74 |
| 52 Week Low | $20.57 | $10.80 |
| 52 Week High | $36.70 | $19.85 |
| Indicator | FG | SHC |
|---|---|---|
| Relative Strength Index (RSI) | 71.59 | 46.55 |
| Support Level | $28.75 | $15.18 |
| Resistance Level | $29.63 | $16.55 |
| Average True Range (ATR) | 0.75 | 0.45 |
| MACD | 0.14 | -0.07 |
| Stochastic Oscillator | 98.32 | 40.57 |
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical, and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three reportable segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment, which generates maximum revenue, provides outsourced terminal sterilization and irradiation services for medical devices, pharmaceuticals, food safety, and other application markets using three core technologies: gamma irradiation, EO processing, and E-beam irradiation. Geographically, the company generates maximum revenue from the United States, followed by Canada, Europe, and other regions.